Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8662873 | International Journal of Cardiology | 2017 | 6 Pages |
Abstract
These contemporary prospective UK data demonstrate improvements in HRQoL and functional status with ivabradine therapy in typical older CHF patients. Despite comorbidities and polypharmacy, ivabradine was well tolerated.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
D. Zachariah, D. Stevens, G. Sidorowicz, C. Spooner, N. Rowell, J. Taylor, R. Kay, M.S. Salek, P.R. Kalra, on behalf of the LIVE:LIFE study investigators on behalf of the LIVE:LIFE study investigators,